Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q3 FY2020 Earnings Presentation
16 slides from Neogen Chemicals's earnings presentation, Feb 8, 2020
Slide 1: Q3 & 9M FY20 Earnings Presentation
Neogen Chemicals Ltd. Q3 & 9M FY20 Earnings Presentation February 2020 NEOGEN CHEMICALS LTD.
Slide 2: Safe Harbour
Safe Harbour 2 Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ
Slide 3: Table of Contents
Table of Contents 3 4 6 7 12 13 14 15 30 Introduction Q3 & 9M Historical Competitive Management Way to Neogen FY20 Financial Contact Us Advantages Commentary Forward Chemicals Financial Trends Performance
Slide 4: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance 4 Leading manufacturer of Bromine and Lithium-based specialty chemicals, operating since 1991 205 10°/o Products developed Of workforce in Strong portfolio of Organic and Inorganic products by in-house R&D R&D team Customers across multiple industries including Pharma,
Slide 5: Business Overview and Clientele
Business Overview 5 Organic Chemicals Inorganic Chemicals The portfolio includes specialty, inorganic Custom Synthesis & lithium-based chemical products which Bromine Compounds Advanced Intermediates Manufacturing find applications across multiple industries Organic compounds containing Combining br
Slide 6: Competitive Advantages
Competitive Advantages 6 Large and diverse array of products Strong Manufacturing Capabilities Experienced promoters with domain knowledge Diversified and Stable Established and stable Customer Base relationship with suppliers Specialised Business Model Continuous Investment with high entry barriers
Slide 7: Key Performance Highlights – Q3 FY20
Key Performance Highlights – Q3 FY20 7 Rs. 82.29 cr 0 30.2% Revenue break-up Revenues Rs. 15.99 cr 0 53.8% *Exports, EBITDA 36% Domestic, 64% Rs. 11.53 cr 0 69.1% Profit Before Tax Rs. 8.22 cr 0 90.7% *Including deemed exports Profit After Tax Note: Growth for Q3 FY20 is compared to Q3 FY19
Slide 8: Financial Summary – Q3 FY20
Financial Summary – Q3 FY20 8 REVENUE EBITDA PAT 82.3 16.0 8.2 I• 63.2 I• 10.4 I•• 4.4 •• •• • Q3 FY19 Q3 FY20 Q3 FY19 Q3 FY20 Q3 FY19 Q3 FY20 Rs. crore Rs. crore Rs. crore Growth momentum in Q3 EBITDA demonstrated strong All round robust performance FY20 continued on the back of growth with margin
Slide 9: Revenue break-up
Revenue break-up 9 Q3 FY20 Q3 FY19 9M FY20 9M FY19 23% Rs. 70 cr. Rs. 57 cr. 44% Rs. 182 cr. Rs. 126 cr. Organic Chemicals 100% Rs. 12 cr. Rs. 6cr. 27% Rs. 42 cr. Rs. 33 cr. Inorganic Chemicals
Slide 10: Seasonal Variance Factors
Seasonal Variance Factors 10 • Neogen’s business has some seasonal drivers, due to which the company tends to deliver stronger financial performance in the second half of the financial year (October to March). Seasonal variance is driven by strong demand from Europe as orders tend to scale up in Oct
Slide 11: Financial Table – Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) 11 Particulars (Rs. crore) Q3 FY20 Q3 FY19 Growth (%) 9 M FY20 9 M FY19 Growth (%) Revenue 82.3 63.2 30.2% 223.8 159.2 40.6% Expenditure 66.3 52.8 25.6% 181.6 132.1 37.5% EBITDA 16.0 10.4 53.8% 42.2 27.1 55.7% Margins 19.4% 16.5% 18.9% 17.0% Dep
Slide 12: Management Commentary
Management Commentary 12 Commenting on the Q3 FY20 performance, Mr. Haridas Kanani, Chairman & Managing Director, at Neogen Chemicals said: “I am glad to state that we have sustained our growth momentum during the quarter under review, on the back of expected gains in both Organic as well as Inorgan
Slide 13: Historical Financial Trends
Historical Financial Trends 13 Net Revenue from Operations** EBITDA (INR crore) Margin (%) (INR crore) 18.1% 17.8% 18.2% 15.4% 15.0% 14.0% 239 163 101 111 74 85 12 13 14 20 29 43 FY14 FY15 FY16 FY17 FY18 FY19 FY14 FY15 FY16 FY17 FY18 FY19 ** Revenue is Net of Excise PAT (INR crore) Margin (%) Networ
Slide 14: Way Forward
Way Forward 14 Increasing Custom Synthesis & Manufacturing portfolio Augmenting growth in domestic and global markets Expanding production capacities Focus on advanced speciality intermediates Focus on operational efficiency and functional excellence
Slide 15: Contact Us
Contact Us 15 About Neogen Chemicals Limited For further information, please contact: Incorporated in 1991, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is one of India’s leading manufacturers of Bromine-based and Lithium-based specialty chemicals. It’s specialty chemicals product offe
Slide 16: Thank You
')( .~ .. NEOGEN ~ CHEMICALS LTD. A Thank You